Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
0.205
-0.005 (-2.34%)
Nov 21, 2024, 11:01 AM EST - Market open
Bionano Genomics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Operating Revenue | 33.33 | 36.12 | 27.8 | 17.98 | 8.5 | 10.13 | Upgrade
|
| Revenue | 33.33 | 36.12 | 27.8 | 17.98 | 8.5 | 10.13 | Upgrade
|
| Revenue Growth (YoY) | -0.82% | 29.90% | 54.62% | 111.47% | -16.06% | -15.59% | Upgrade
|
| Cost of Revenue | 33.93 | 26.55 | 21.86 | 14.11 | 5.73 | 6.77 | Upgrade
|
| Gross Profit | -0.6 | 9.57 | 5.95 | 3.87 | 2.77 | 3.36 | Upgrade
|
| Selling, General & Admin | 57.26 | 94.96 | 86.48 | 56.92 | 29.57 | 20.16 | Upgrade
|
| Research & Development | 33.03 | 54.03 | 49.05 | 22.49 | 10.26 | 9.08 | Upgrade
|
| Operating Expenses | 90.29 | 148.99 | 135.53 | 79.41 | 39.82 | 29.24 | Upgrade
|
| Operating Income | -90.89 | -139.43 | -129.58 | -75.54 | -37.05 | -25.87 | Upgrade
|
| Interest Expense | -5.12 | -5.12 | -0.3 | -0.93 | -2.52 | -2.29 | Upgrade
|
| Interest & Investment Income | 3.07 | 3.31 | 1.51 | 0.24 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -16.74 | -15.38 | -0.12 | -0.06 | -0.01 | -0.3 | Upgrade
|
| EBT Excluding Unusual Items | -109.68 | -156.61 | -128.5 | -76.29 | -39.58 | -28.46 | Upgrade
|
| Merger & Restructuring Charges | -7.62 | - | -1.8 | -1.5 | -1.5 | - | Upgrade
|
| Impairment of Goodwill | - | -77.28 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -0.1 | - | - | - | Upgrade
|
| Asset Writedown | -19.95 | - | - | - | - | - | Upgrade
|
| Other Unusual Items | 1.46 | 1.46 | -0.32 | -0.37 | - | -1.33 | Upgrade
|
| Pretax Income | -135.79 | -232.43 | -130.71 | -78.15 | -41.08 | -29.79 | Upgrade
|
| Income Tax Expense | -0 | 0.06 | 1.88 | -5.72 | 0.03 | 0.02 | Upgrade
|
| Net Income | -135.78 | -232.49 | -132.6 | -72.44 | -41.11 | -29.82 | Upgrade
|
| Net Income to Common | -135.78 | -232.49 | -132.6 | -72.44 | -41.11 | -29.82 | Upgrade
|
| Shares Outstanding (Basic) | 71 | 34 | 29 | 28 | 10 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 71 | 34 | 29 | 28 | 10 | 1 | Upgrade
|
| Shares Change (YoY) | 123.96% | 18.08% | 4.49% | 165.50% | 596.03% | 111.64% | Upgrade
|
| EPS (Basic) | -1.92 | -6.81 | -4.58 | -2.62 | -3.94 | -19.91 | Upgrade
|
| EPS (Diluted) | -1.92 | -6.81 | -4.58 | -2.62 | -3.94 | -19.91 | Upgrade
|
| Free Cash Flow | - | -126.87 | -128.02 | -73.39 | -38.31 | -29.59 | Upgrade
|
| Free Cash Flow Per Share | - | -3.72 | -4.43 | -2.65 | -3.68 | -19.76 | Upgrade
|
| Gross Margin | -1.80% | 26.49% | 21.38% | 21.54% | 32.61% | 33.18% | Upgrade
|
| Operating Margin | -272.66% | -386.05% | -466.09% | -420.08% | -435.74% | -255.44% | Upgrade
|
| Profit Margin | -407.34% | -643.74% | -476.93% | -402.84% | -483.43% | -294.34% | Upgrade
|
| Free Cash Flow Margin | - | -351.29% | -460.46% | -408.14% | -450.59% | -292.12% | Upgrade
|
| EBITDA | -78.02 | -125.72 | -119.96 | -72.18 | -35.57 | -24.75 | Upgrade
|
| EBITDA Margin | -234.07% | - | - | - | - | -244.31% | Upgrade
|
| D&A For EBITDA | 12.87 | 13.71 | 9.62 | 3.35 | 1.48 | 1.13 | Upgrade
|
| EBIT | -90.89 | -139.43 | -129.58 | -75.54 | -37.05 | -25.87 | Upgrade
|
| EBIT Margin | -272.66% | - | - | - | - | -255.44% | Upgrade
|
| Revenue as Reported | 33.33 | 36.12 | 27.8 | 17.98 | 8.5 | 10.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.